VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	9/17/2010 10:32:03 AM
	of 1972

Vical (VICL) and GenVec (GNVC) Could See Interest on Crucell Deal News Smaller vaccine stocks could see interest today following news that Crucell NV (Nasdaq: CRXL) is in advanced talks to be acquired by JJ (NYSE: JNJ). Vical Inc. (Nasdaq: VICL) and GenVec, Inc. (Nasdaq: GNVC) are two smaller vaccine makers. GenVec closed yesterday at $0.50 and Vical at $3.64.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next